Kelleher Financial Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,150
Closed -$107K 108
2020
Q2
$107K Buy
+12,150
New +$61.4K 0.1% 97
2018
Q4
$140K Buy
15,300
+1,000
+7% +$11.1K 0.22% 75
2018
Q3
$177K Hold
14,300
0.23% 87
2018
Q2
$218K Hold
14,300
0.31% 76
2018
Q1
$283K Buy
14,300
+1,000
+8% +$17.3K 0.39% 69
2017
Q4
$248K Buy
13,300
+2,400
+22% +$48.2K 0.39% 67
2017
Q3
$234K Sell
10,900
-2,000
-16% -$31.6K 0.49% 64
2017
Q2
$124K Buy
+12,900
New +$83.8K 0.24% 78
2014
Q4
Sell
-3,650
Closed -$60K 118
2014
Q3
$60K Hold
3,650
0.03% 114
2014
Q2
$58K Hold
3,650
0.03% 109
2014
Q1
$65K Buy
+3,650
New +$67.7K 0.04% 105

Other funds holding DVAX

Kelleher Financial Advisors's DVAX Position: Q3 2020 in Review

Kelleher Financial Advisors sold out of Dynavax Technologies (DVAX) in Q3 2020, closing a stake of 12,150 shares — an estimated $107K sold.

Kelleher Financial Advisors first reported a position in DVAX in Q1 2014 and held it in 11 quarters. The position peaked at $283K in Q1 2018. 165 funds tracked by Wall St. Rank hold DVAX as of Q3 2020.

  • Kelleher Financial Advisors reported no remaining Dynavax Technologies position as of Q3 2020 after selling out during the quarter.
  • Kelleher Financial Advisors sold 12,150 Dynavax Technologies shares in Q3 2020, an estimated $107K.
  • Kelleher Financial Advisors first reported a position in Dynavax Technologies in Q1 2014 and held it in 11 quarters.
  • Kelleher Financial Advisors's Dynavax Technologies position peaked at $283K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2020.

Based on Kelleher Financial Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.